Trademark: 90238043
Word
AUDUBON
Status
Registered
Status Code
700
Status Date
Tuesday, January 4, 2022
Serial Number
90238043
Registration Number
6605265
Registration Date
Tuesday, January 4, 2022
Mark Type
3000
Filing Date
Tuesday, October 6, 2020
Published for Opposition
Tuesday, May 18, 2021

Trademark Owner History
Audubon Health Group, LLC - Original Registrant

Classifications
42 Providing medical and scientific research information in the field of human pharmaceuticals and human clinical trials; conducting research and clinical trials in the field of human oncology and cancer research; Providing a website featuring educational information in the field of human clinical research; Medical and scientific research, namely, conducting human clinical trials for others; Providing human medical testing services and information in the field of human cancer research and disease classification; technical research and consulting in the field of human pharmaceutical studies; Human pharmaceutical research services; human Pharmaceutical research and development; testing of human pharmaceuticals; Biotechnology research related to humans; Medical research related to humans; Human DNA analysis services for scientific research purposes; Human medical and scientific research in the field of molecular profiling and biomarker discovery in cancer patients; human medical and scientific research in the field of cancer treatment; Providing research information in the nature of human medical research data pertaining to cancer and its treatment; Management of clinical and translational trials in the field of human cancer treatment for others in the nature of conducting clinical trials for others; Providing clinical trial information in the nature of research data pertaining to cancer; development, validation, and certification of human clinical trials and tests; Design, research, development and testing services in the field of human pharmaceuticals, biobanking, and cancer research; Preclinical research services in the field of human biospecimens collections
44 collection and preservation of human biologicals, namely, human tissue, blood and bodily fluids; Biobank services, namely, providing access to a collection of human biologicals, namely, human tissue, blood and bodily fluids; Providing human medical information in the nature of medical data pertaining to cancer and its treatment; providing tissue biobank services, namely, access to a biobank of human biological and tissue samples; Human medical testing for diagnostic or treatment purposes; Dispensing of pharmaceuticals to humans
The colors yellow, pink, purple, and black are claimed as a feature of the mark.
The mark consists of the word "AUDUBON" in black with an image of a cell to the left stylized so that the varying cell structures are shaded differently and the membranes between the structures are frayed to look like a pompom. The cell having a yellow center, followed by a pink layered border and a purple border on the outside.

Trademark Events
Jan 4, 2022
Registered-Principal Register
Nov 25, 2021
Extension Of Time To Oppose Process - Terminated
Nov 24, 2021
Changes/Corrections After Pub Approval Entered
Nov 24, 2021
Assigned To Petition Staff
Nov 12, 2021
Teas Post Publication Amendment Received
Jun 16, 2021
Extension Of Time To Oppose Received
May 18, 2021
Official Gazette Publication Confirmation E-Mailed
May 18, 2021
Published For Opposition
Apr 28, 2021
Notification Of Notice Of Publication E-Mailed
Apr 13, 2021
Approved For Pub - Principal Register
Apr 13, 2021
Examiner's Amendment Entered
Apr 13, 2021
Notification Of Examiners Amendment E-Mailed
Apr 13, 2021
Examiners Amendment E-Mailed
Apr 13, 2021
Examiners Amendment -Written
Mar 9, 2021
Notification Of Non-Final Action E-Mailed
Mar 9, 2021
Non-Final Action E-Mailed
Mar 9, 2021
Non-Final Action Written
Mar 4, 2021
Assigned To Examiner
Nov 21, 2020
Notice Of Design Search Code E-Mailed
Nov 20, 2020
New Application Office Supplied Data Entered In Tram
Oct 9, 2020
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24